PDT Partners’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $74.6K | Sell |
20,097
-34,902
| -63% | -$129K | ﹤0.01% | 675 |
|
|
2025
Q1 | $178K | Sell |
54,999
-5,916
| -10% | -$19.1K | 0.01% | 685 |
|
|
2024
Q4 | $339K | Buy |
+60,915
| New | +$339K | 0.03% | 548 |
|
|
2024
Q3 | – | Sell |
-39,356
| Closed | -$826K | – | 755 |
|
|
2024
Q2 | $826K | Sell |
39,356
-20,768
| -35% | -$436K | 0.08% | 372 |
|
|
2024
Q1 | $1.92M | Buy |
+60,124
| New | +$1.92M | 0.18% | 202 |
|
|
2023
Q2 | – | Sell |
-10,795
| Closed | -$186K | – | 601 |
|
|
2023
Q1 | $186K | Sell |
10,795
-10,007
| -48% | -$172K | 0.03% | 505 |
|
|
2022
Q4 | $462K | Buy |
20,802
+2,083
| +11% | +$46.3K | 0.07% | 406 |
|
|
2022
Q3 | $151K | Buy |
+18,719
| New | +$151K | 0.02% | 752 |
|